相关实验视频
Updated: Jun 12, 2025

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.3K
在法国,谁有严重过敏反应的风险?
Luciana Kase Tanno1,2,3, Pham Thao Van Luong2, Megane Dieval4
1Division of Allergy, Department of Pulmonology, Allergy and Thoracic Oncology, University Hospital of Montpellier, Montpellier, France.
The World Allergy Organization journal
|September 19, 2024
概括
这项法国研究显示,严重过敏反应 (SA) 常常是由药物引起的,特别是在女性中,而食物过敏在儿童中很常见. 了解这些风险因素对于预防至关重要.
科学领域:
- 公共卫生 公共卫生
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 严重过敏反应 (SA) 风险因素对于有效的预防策略至关重要.
- 这项研究是第一个以人口为基础,对法国过敏反应住院病人的9年分析.
- 它旨在确定严重过敏反应的风险表型.
研究的目的:
- 分析与法国人口中严重过敏反应 (SA) 相关的趋势和风险因素.
- 为了确定患有严重过敏反应风险的特定表型.
- 为公众健康行动和对过敏反应的预防策略提供信息.
主要方法:
- 利用来自法国住院数据库 (2012-2021) 的描述性数据.
- 包括所有住院患有过敏反应的患者 (ICD-10代码作为初级诊断).
- 定义SA病例为需要重症监护室 (ICU) 住院或导致死亡的病例.
主要成果:
- 过敏反应住院率为每年1.34/100,000;SA率为每年0.08/100,000.
- 已确定SA的触发因素:药物 (45.6%),食物 (9.3%),昆虫刺伤 (7.2%).
- 药物触发的SA在女性中较高;食物触发的SA在儿童中常见 (5-9岁);昆虫刺伤SA仅在青少年 (10-14岁). 慢性自发性疹与昆虫SA相关;与所有SA原因相关的血管;与药物/食物SA相关的喘和过敏史.
结论:
- 介绍了法国严重过敏反应现象类型的第一个数据.
- 强调确定SA的触发因素和相关条件的重要性.
- 强调需要数据驱动的公共卫生行动,以改善过敏反应治疗和预防.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Adrenergic Agonists: Therapeutic Uses
749
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
749
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Hypersensitivities
550
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
550
Allergic Drug Reactions
818
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
818
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245

